Carbamoylation of glomerular and tubular proteins in patients with kidney failure: A potential mechanism of ongoing renal damage

Swiss Medical Weekly

Volumn 131, Issue 11-12, 2001, Pages 139-145

  Kraus, L M ^a   Gaber, L ^a   Handorf, C R ^a   Marti, H P ^a   Kraus A P , Jr ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Carbamoylation; Cyanate; Matrix metalloproteinase 2; Urea

Indexed keywords

COMPLEMENT; CYANIC ACID; GELATINASE A; HOMOCITRULLINE; IMMUNOGLOBULIN; UREA;

ADOLESCENT; ADULT; AGED; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN TISSUE; KIDNEY BIOPSY; KIDNEY FAILURE; KIDNEY INJURY; KIDNEY TRANSPLANTATION; KIDNEY TUBULE; MALE; MESANGIUM; NONHUMAN; PRESCHOOL CHILD; PROTEIN MODIFICATION; RAT; UREA NITROGEN BLOOD LEVEL;

EID: 0035941951     PISSN: 14247860     EISSN: None     Source Type: Journal    
DOI: 10.4414/smw.2001.09691     Document Type: Article

References (37)

1. Potassium cyanate as an inhibitor of the sickling of erythrocytes in vitro
2. Role of the lysine residues of plasma lipoproteins in high affinity binding to cell surface receptors on human fibroblasts
3. The search for the uremic toxin: The case for carbamoylation of amino acids and proteins
4. The isomeric transformation of urea into ammonium cyanate in aqueous solution
5. The effect of cyanate upon the stability of proteins
6. Reaction of cyanate with functional groups of proteins III. Reactions with amino and carboxyl groups
7. Analysis for homocitrulline
8. Carbamoylation of hemoglobin in uremic patients determined by antibody specific for homocitrulline (carbamoylated e-N-Lysine)
9. Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: Generation of antibodies specific for derivatized lysine
10. Carbamoylation vs. AGE formation in ESRD alone or in combination with NIDDM
11. Urea-derived cyanate forms ε-amino-carbamoyl-lysine (homocitrulline) in leukocyte proteins in patients with end-stage renal disease on peritoneal dialysis
12. Matrix accumulation in mesangial cells exposed to cyclosporine A requires a permissive genetic background
13. Homology cloning of rat 72 kDa type IV collagenase: Cytokine and second -messenger inducibility in glomerular mesangial cells
14. Human mesangial cells secrete GBM-degrading neutral proteinase and a specific inhibitor
15. Rat mesangial cells and matrix metalloproteinase inhibitor: Inhibition of 72-kD type IV collagenase (MMP-2) and of cell proliferation
16. A novel coumarin-labeled peptide for sensitive continuous assays of the matrix metalloproteinases
17. Molecular characterization of a low-molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as Pump- 1
18. Pathophysiology of progressive nephropathies
19. Sodium cyanate induced polyneuropathy in patients with sickle cell disease
20. Cyanate-induced cataracts in patients with sickle cell hemoglobinopathies
21. Reactions of the cyanate present in aqueous urea with amino acids and proteins
22. Carbamyl phosphate-cyanate and CNS toxicity
23. Urea induces heat shock response in human neuroblastoma cells
24. Physiological and clinical implications of protein carbamylation
25. Inactivation of chymotrypsin by cyanate
26. Inactivation of bovine glutamate dehydrogenase by carbamoyl phosphate and cyanate
27. Carbamylation of insulin and its biological activity
28. Carbamylation of amino and tyrosine hydroxyl groups: Separation of an inhibitor of oxytocin with no intrinsic activity on the isolated uterus
29. Proteinases and glomerular matrix turnover
30. Matrix metalloproteinase 2 (gelatinase A) regulates glomerular mesangial cell proliferation and differentiation
31. Carbamoylation of plasma proteins in CAPD and HD
32. Carbamylated haemoglobin in chronic renal failure
33. Differentiation of acute from chronic renal impairment by detection of carbamylated haemoglobin
34. Factors determining hemoglobin carbamylation in renal failure
35. Carbamylated hemoglobin: A potential marker for adequacy of hemodialysis therapy in end-stage renal failure
36. Glycosylated and carbamylated haemoglobin in uraemia
37. Gene gating: A hypothesis